Study to Evaluate the Safety and Tolerability of EP0042

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Acute Myeloid Leukemia · Chronic Myelomonocytic Leukemia · Myelodysplastic Syndromes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Royal Perth Hospital, Perth, Western Australia, Australia
Amsterdam UMC, Amsterdam, Netherlands
Erasmus MC, Rotterdam, Netherlands
The Royal Marsden, London, UK, United Kingdom
University College London Hospital, London, United Kingdom
The Christie Hospital, Manchester, United Kingdom

Study leads

David Taussig
Principal Investigator
The Royal Marsden, UK

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Acute Myeloid Leukemia · Myelodysplastic Syndromes · Chronic Myelomonocytic Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Rochester, United States

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Brain and Central Nervous System Tumors · Chronic Myeloproliferative Disorders · Leukemia

Abroad (travel likely)Recruiting

Detroit, United States

A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.

Acute Myeloid Leukemia (AML) · Myelodysplastic Syndromes (MDS)

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Guangzhou, China

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

Acute Leukemia of Ambiguous Lineage · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States